Qsymia for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Sep 2014: Trial registered, NCT02229214

The trials

NCT02229214: Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects

State
Completed
Phase
Phase 4
People
51 taking part
Started
Aug 2014
Primary completion
Nov 2014
Arms
VI-0521 (Qsymia)
Results
Posted on the registry
  1. 1 Sep 2014: Trial registered
  2. 9 Feb 2016: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.